Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and Toxicity
Author:
Funder
Novartis
Pfizer
Genentech
Roche
Astellas Pharmaceuticals
Vanderbilt-Ingram Cancer Center
National Center for Advancing Translational Sciences
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference42 articles.
1. Prognostic significance of subtype and pathologic response in operable breast cancer: a pooled analysis of prospective neoadjuvant studies of JBCRG;Kuroi;Breast Cancer,2015
2. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer;Liedtke;J Clin Oncol,2008
3. The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer;Jones;Breast Cancer Res Treat,2009
4. A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy;Guarneri;Ann Oncol,2009
5. The fate of chemoresistance in triple negative breast cancer (TNBC);O’Reilly;BBA Clin,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy;Journal of Vascular and Interventional Radiology;2024-09
2. Management and outcomes of breast cancer patients with radiotherapy interruption;Frontiers in Oncology;2024-07-23
3. The neoadjuvant approach to treatment of breast cancer: Multidisciplinary management to improve outcomes;Surgical Oncology Insight;2024-06
4. Preoperative Radiation Therapy for Chemorefractory Localized Inflammatory Breast Cancer;Practical Radiation Oncology;2023-11
5. Radiation Management for Breast Cancer After Neoadjuvant Therapy;Current Breast Cancer Reports;2023-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3